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Objective: The protective mechanisms that maintain periodontal homeostasis in
gingivitis and prevent periodontal tissue destruction are poorly understood. The aim of
this study was to identify changes in the salivary proteome during experimental gingivitis.
Study design: We used oral neutrophil quantification and whole saliva (WS) proteomics
to assess changes that occur in the inflammatory and resolution phases of gingivitis
in healthy individuals. Oral neutrophils and WS samples were collected and clinical
parameters measured on days 0, 7, 14, 21, 28, and 35.
Results: Increased oral neutrophil recruitment and salivary cytoprotective proteins
increased progressively during inflammation and decreased in resolution. Oral neutrophil
numbers in gingival inflammation and resolution correlated moderately with salivary
β-globin, thioredoxin, and albumin and strongly with collagen alpha-1 and G-protein
coupled receptor 98.
Conclusions: Our results indicate that changes in salivary cytoprotective proteins in
gingivitis are associated with a similar trend in oral neutrophil recruitment and clinical
parameters.
Clinical relevance: We found moderate to strong correlations between oral neutrophil
numbers and levels of several salivary cytoprotective proteins both in the development
of the inflammation and in the resolution of gingivitis. Our proteomics approach identified
and relatively quantified specific cytoprotective proteins in this pilot study of experimental
gingivitis; however, future and more comprehensive studies are needed to clearly identify
and validate those protein biomarkers when gingivitis is active.
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Aboodi et al. Salivary Proteome in Experimental Gingivitis
INTRODUCTION
Periodontal diseases are a diverse group of inherited or acquired
conditions that affect the tooth-supporting tissues in more than
half of world population. Different pathogenic mechanisms
including inflammatory, traumatic, genetic, and neoplastic
contribute to the onset and progression of periodontal diseases
(Madianos et al., 2005). The main etiologic factor for these
conditions is the bacterial biofilm while the most common forms
of periodontal diseases are plaque-induced gingivitis (GI) and
chronic periodontitis (CP).
Plaque-induced gingivitis (GI) is defined as an inflammation
of the gingiva induced by bacteria located at the gingival
margin. The causative relationship between bacterial plaque
(biofilm) and gingival inflammation was well demonstrated
in experimental gingivitis (Loe et al., 1965). Characteristic GI
clinical signs include erythema, edema, loss of gingival stippling,
and bleeding upon probing (Mariotti, 1999). Interestingly,
the host response to similar plaque levels varies significantly
among patients (Trombelli et al., 2004). Histologic changes
in the tissue include proliferation of junctional epithelium,
vasculitis of blood vessels adjacent to the junctional epithelium,
collagen degradation, cytopathologic alteration of fibroblasts,
and inflammatory infiltrate (Page and Schroeder, 1976). GI
is reversible upon removal of the etiologic biofilm (Loe et al.,
1965). CP is characterized by extension of gingival inflammation
to the alveolar bone, connective tissue degradation, and net
loss of tooth attachment to periodontium (American Academy
of Periodontology, 2000). The transition from GI to CP is
incompletely understood. On the one hand, GI is an established
risk factor for CP (Lang et al., 2009). On the other hand, clinical
studies have demonstrated that in some individuals GI never
progresses to CP, regardless of periodontal care (Pihlstrom et al.,
2005).
Although certain pathogenic bacteria in subgingival biofilms
produce specific virulence factors that could cause direct damage
to periodontal tissues, current evidence suggest that it is the host
factors that drive periodontal tissue degradation at sites with CP.
These factors include an increase abundance of inflammatory
cytokines, host proteolytic enzymes, and increased oxidative
stress (Chapple and Matthews, 2007; Bartold et al., 2010). The
rate limiting steps in onset and progression of clinical attachment
loss are incompletely understood. Increasing evidence that
emerged in recent years indicates that failure to resolve biofilm-
induced periodontal inflammation results in chronicity and pro-
osteolytic environments (Bartold and Van Dyke, 2013; Freire and
Van Dyke, 2013; Van Dyke, 2014). Well-functioning resolution
programs in periodontal tissues may be more critical that in
other tissues because as a result of continuous challenge by
subgingival bacteria, neutrophils traffic between the vasculature,
gingival tissues, and gingival crevicular fluid (GCF) to maintain
the host–biofilm balance, prevent tissue invasion by pathogens
and ultimately bone loss.
The development of proteomics techniques allows us to
identify, characterize and quantitate large numbers of proteins
in a single study (Neilson et al., 2011). Utilizing proteomics in
periodontitis research may reveal changes in the protein profile
(proteome) during disease progression and the identification of
disease-specific biomarkers (Baliban et al., 2012). WS and GCF
samples were used for proteome analysis during GI (Ozdemir
et al., 2009; Grant et al., 2010; Gonçalves Lda et al., 2011) and
CP (Gonçalves Lda et al., 2010; Baliban et al., 2012; Rangé
et al., 2012; Salazar et al., 2013; Silva-Boghossian et al., 2013).
Blood proteins levels were reported to increase in both CP and
GI patients (Gonçalves Lda et al., 2010, 2011), confirming the
inflammatory nature of both diseases. While GCF and tissue
samples provide site-specific information, salivary proteome
analysis provides a comprehensive approach to oral health status,
as WS proteins are originated from numerous sources (salivary
glands, mucosal cells, immune cells, serum, and bacteria). The
purpose of the current investigation was to identify changes
in proteome profile during the development, progression and
resolution of GI in an EG (experimental gingivitis) model.
Findings of specific cytoprotective proteins and their correlation
with clinical parameters and oral neutrophil numbers may
suggest different protective mechanisms during GI that prevent
tissue destruction and attachment loss that can be used for disease




Twenty-one day experimental gingivitis (EG) model was used
to investigate protein dynamics at health (day 0 of EG) and GI
(day 21 of EG). Study design and goals were presented to all
participants, and consent was obtained in writing. The study
was approved by the Scientific and Ethics Review Boards at the
University of Toronto (protocols #24295/#24567) and conducted
in the Graduate Periodontics Clinic at the Faculty of Dentistry
from September–December 2012. Five periodontally healthy
participants (2 males, 3 females, age range 20–36) completed EG
trial. All study participants were systemically healthy and non-
smokers. Participants completed baseline periodontal exam and
professional scaling by a registered dental hygienist, followed
by 7 days of enhanced oral hygiene (pre-study hygiene phase).
On day 0 of EG, full periodontal exam was completed, and
participants were asked to refrain from any oral hygiene
procedures (including brushing, flossing, use of mouthwash, and
gum chewing) for the remainder of the trial. EG inflammatory
phase was concluded after 21 days. Oral neutrophils and WS
samples were collected and clinical parameters measured on
days 0, 7, 14, 21, 28, and 35. Participants received scaling
and oral hygiene instructions. Participants were followed for
2 weeks during healing phase (Figure 1). During the trial,
participants were followed weekly. Full periodontal exam and
sample collection was completed at each visit. EG participants
were used both as healthy control group (EG0–day 0 samples)
and GI group (EG21–day 21 samples).
Oral Neutrophil Quantification
Oral neutrophil quantification was completed utilizing
hemocytometer technique, as previously described (Landzberg
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FIGURE 1 | Experimental gingivitis trial design flow chart (days). Stimulated whole saliva samples were collected at each time point.
et al., 2015). Rinse samples for oral neutrophil cell counts were
collected prior to any periodontal instrumentation to avoid
sample contamination with blood. Subjects were asked to rinse
with 10mL of 0.9% isotonic sodium chloride solution (Baxter,
Toronto, ON) for 30 s, and then expectorate into a 50mL
polypropylene tube (Sigma-Aldrich, St. Louis, MO). A 500µl
sample was separated into an 1.5ml polypropylene tube and
fixed with 50µl with 37% formaldehyde (Sigma-Aldrich, St.
Louis, MO). Samples were kept in 4◦C until analysis. All cell
counts were completed by the same examiner (GMA). Samples
were centrifuged at 1139 × g for 5min (Hettich Zentrifugen,
Tuttlingen, Germany). The supernatant was removed and the
pellet was resuspended in 100µL of phosphate buffered saline
(PBS. Sigma-Aldrich, St. Louis, MO). One microliter acridine
orange (Sigma Chemical, Burlington, ON, Canada) was added
to the cell suspension. Acridine orange is a fluorescent nucleic
acid marker. Its interaction with DNA and RNA allows the
identification of neutrophils under fluorescence microscope.
Following acridine orange staining, samples were incubated, light
protected, for 15min at room temperature. A 10µL aliquot of
this suspension was loaded on to a hemocytometer (Bright-Line;
Hausser Scientific, Horsham, PA, USA), and the neutrophils
were visually counted using fluorescence microscopy (Leitz
Orthoplan Microscope; Leitz, Wetzlar, Germany). Neutrophils
were counted and quantified based on the standard protocol for
hemocytometer use.
Whole Saliva (WS) Sample Collection and
Preparation
Stimulated WS samples were collected prior to any periodontal
instrumentation to avoid sample contamination with blood.
Chewing has been demonstrated to increase GCF flow, therefore
subjects were asked to chew on a 5×5 cm parafilm (around 1.4 g,
Parafilm M, Brand, Wertheim, Germany). This allowed for an
increased GCF component in the analyzedWS samples (Griffiths,
2003). All EG sample collection took place in the morning, at the
same time for each subject. Stimulated saliva in the first 30 s was
discarded (swallowed). Patients were then asked to expectorate
stimulated saliva into a 50ml polypropylene tube (Sigma-
Aldrich, St. Louis, MO) until 15ml were collected. Salivary flow
rate (ml/min) was acquired for each saliva collection. Saliva
samples were placed on ice until aliquoting, which was completed
within 3 h of sample collection. Samples were aliquoted into
1ml portions. Three 1ml samples were kept at −80◦C until
analysis and analyzed as whole saliva samples. Six 1ml samples
were centrifuged at 14,000 g over 20min (Eppendorf Centrifuge
5415R, Eppendorf, Hauppauge, NY). Supernatant was separated
from pellet, and both were kept at −80◦C until analysis. The
remaining 6ml were stored at−80◦C andwere used as a reservoir
for additional testing (Siqueira et al., 2004). Our goal was to
establish a disease-specific proteome profile and a trend that
characterizes the inflammatory and healing phases of gingival
inflammation rather than individual investigations. Therefore,
samples for each of the study groups were pooled together
(Siqueira et al., 2012). As previously described (Silva-Boghossian
et al., 2013), pooled samples were denatured and reduced for 2 h
by buffer containing 4M urea, 10mM dithiothreitol (DTT), and
50mM ammonium bicarbonate (NH4HCO3), pH 7.8. Following
dilution with 50mM ammonium bicarbonate and the addition
of 2% w/w sequencing-grade trypsin (Promega, Madison, WI),
tryptic digestion was carried out for 18 h at 37◦C.
Liquid Chromatography Electrospray
Ionization Tandem Mass Spectrometry
(LC-ESI-MS/MS)
Mass spectrometric analyses were carried out with a LTQ-Velos
(Thermo Scientific, San Jose, CA, USA) which allows in-line
liquid chromatography with the capillary fused silica C18 column
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(column length 10mm, column ID 75µm, 3µm spherical beads
and 100 Å pores size) linked to mass spectrometer using an
electrospray ionization in a survey scan in the range of m/z
values 390–2000 tandem MS/MS. All samples were dried by
rotary evaporator and re-suspended in 20µL of 97.5%H2O/2.4%
acetonitrile/0.1% formic acid and then subjected to reversed-
phase LC-ESI-MS/MS. The nano-flow reversed-phase HPLC was
developed with linear 80-min gradient ranging from 5 to 55% of
solvent B (97.5% acetonitrile, 0.1% formic acid) at a flow rate of
300 nL/min with a maximum pressure of 280 bar. Electrospray
voltage and the temperature of the ion transfer capillary were
1.8 kV and 250◦C, respectively. Each survey scan (MS) was
followed by automated sequential selection of seven peptides for
CID, with dynamic exclusion of the previously selected ions.
The obtained MS/MS spectra were searched against human
protein databases (Swiss Prot and TrEMBL, Swiss Institute of
Bioinformatics, Geneva, Switzerland, http://ca.expasy.org/sprot/)
using SEQUEST algorithm in Proteome Discoverer 1.3 software
(Thermo Scientific, San Jose, CA, USA). Search results were
filtered for a false discovery rate of 1% employing a decoy search
strategy utilizing a reverse database. An additional inclusion
criterion for positive identification of proteins was the same
protein passing the filter score at least in two different MS
analyses from a total of three MS analyses per condition.
Relative Proteome Quantitation
For quantitative proteome analysis, three MS raw files from
each pooled group were analyzed using SIEVE technology
(Version 2.0 Thermo Scientific, San Jose, CA, USA) as previously
described (Siqueira et al., 2012). Relative Proteome quantitation
for day 0 vs. day 21 of EG, were carried out. Baseline samples
were compared to each of the study groups. Initial alignment
step was carried out using a single MS raw file belonging to the
baseline group. This file was selected as the reference file and all
of other files were adjusted accordingly. Following the alignment,
the feature detection and integration (or framing) process was
performed through the “Frames from MS2 Scans” feature,
using the MS level data. This framing process employs only
MS mass-to-charge ratio (m/z) values that were associated with
MS2 scan only. The parameters used consisted of a frame m/z
width of 1500 ppm and a retention time width of 1.75min. Peak
integration was performed for each frame and these values were
used for statistic analysis. Next, peptide sequences obtained from
the database search using SEQUEST algorithm were imported
into SIEVE. Peptides were grouped into proteins and a protein
ratio and p-value were calculated. SIEVE uses a weighted average
of the peptide intensities for the protein calculation. By using the
weighted average, peptides with lower variance in their intensity
measurements have a higher weight on the overall protein ratio.
This is done to decrease variance in protein level quantities based
on variance of the peptides that compose the proteins (Siqueira
et al., 2012).
Correlation Assessment Between Salivary
Proteins Abundance and Oral Neutrophils
Quantification
Pearson correlation was calculated for each of the whole
saliva cytoprotective proteins and the oral neutrophil using
JMP software (SAS, Cary, NC). The association between oral
neutrophil levels and the level of cytoprotective proteins was
tested through correlation analysis during the experimental
gingivitis phase (days 0–21), and the healing period which
followed (days 28–35).
RESULTS
Worsening of clinical inflammatory parameters and biofilm
accumulation were evident in all EG participants by day 21,
including Bleeding on Probing (BOP), and Gingival Index (Löe,
1967). Changes in clinical parameters were detected by day 7,
and increased significantly by day 14 reaching a peak on day
21 and returned to baseline levels by day 35, after subjects
returning to regular OH on day 21. BOP was significantly higher
on days 14 and 21 compared to day 0 and 35 (day 0, 12.8
± 1.6 %; day 7, 22.2 ± 4.4 %; day 14, 36.5 ± 4.6 %; day
21, 38.1 ± 5.1 %; day 28, 30.9 ± 5.2 %; day 35, 19.8 ± 1.4
%; Figure 2A). Similarly, GI increased progressively during the
inflammatory phase and decreased in the healing phase (day 0,
4.4 ± 1.3; day 7, 8.8 ± 0.7; day 14, 11.2 ± 0.4; day 21, 11.6
± 0.24; day 28, 10 ± 0.7; day 35, 8.8 ± 0.4; Figure 2B). A
significant increase in oral neutrophil numbers was found on
day 21 of the inflammatory phase of GI compared to baseline
(Figure 2C). Oral neutrophil counts decreased in the resolution
phase by day 35, reaching levels close to baseline (day 0, 198
± 40 × 104; day 7, 322 ± 32 × 104; day 14, 363 ± 27 × 104;
day 21, 722 ± 44 × 104; day 28, 242 ± 73 × 104; day 35, 220
± 79 × 104).
Salivary flow rate (ml/min) measured during all time-points
of the study demonstrated no statistical significance difference
among the groups (day 7, 1.23 ± 0.08 day 1.23 ± 0.21; day 7,
1.21 ± 0.07; day 14, 1.11 ± 0.09; day 21, 1.11 ± 0.18; day 28,
1.16± 0.19; day 35, 1.21±0.24).
Proteome data analysis revealed that 89 proteins showed
significant level changes (at p < 0.05; Table 1) during EG.
Twenty-one percent of these proteins (25 proteins) demonstrated
a significant increase of at least 2 fold by day 21 compared
to baseline (Table 2). Serum albumin levels identified in WS
samples significantly increased during the inflammatory EG
phase (2.3 fold increase). Furthermore, collagen fragment
abundance increased significantly (7.35 fold increase), in line
with the histologic findings previously described (Page and
Schroeder, 1976).
Significant increases in several cytoprotective proteins
were observed during the inflammatory phase, including
proteins involved in inflammatory regulation (Annexin
A1 and Vitamin D binding protein–4.15 and 2.78 fold
increase, respectively), antibacterial (Lactotransferrin–3.5
fold increase), antioxidants (β-globin and Thioredoxin–3.75
and 2.29 fold increase, respectively), and protease inhibitor
proteins (Cystatin SN, Cystatin S–2.33 and 2.14 fold increase,
respectively; Figure 3A). Abundance of these cytoprotective
proteins went back to baseline levels in the resolution phase
of EG. Eighteen of the 25 salivary proteins that increased
by >2 fold by day 21, followed a trend of reduction in the
resolution phase. Aryl hydrocarbon receptor repressor, cDNA
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FIGURE 2 | Bleeding on Probing (BOP) trend in experimental gingivitis. (A) Bleeding on probing (BOP) was measured at baseline (day 0) and on days 7, 14, 21,
28, and 35 during EG. Mean ± SEM; n = 5; One-way ANOVA with Turkey-Kramer HSD, *p < 0.05 vs. day 0, #p < 0.05 vs. day 21. (B) Gingival index was measured
at baseline (day 0) and on days 7, 14, 21, 28, and 35 during EG. Mean ± SEM; n = 5; One-way ANOVA with Turkey-Kramer HSD, *p < 0.05. (C) Oral neutrophils
isolated from oral rinses collected on days 0, 7, 14, 21, 28, and 35 of EG were quantified using a hemocytometer. Cell numbers were normalized to the rinse volume
collected. Mean ± SEM; n = 5; One-way ANOVA with Turkey-Kramer HSD; *p < 0.05.
FLJ3590 fis and lactotransferrin increased further by day 35
(Figure 3B).
The inflammatory response observed during gingivitis is
mediated by neutrophils migrating from the blood stream to
the gingival tissues and in to the oral cavity through the GCF.
We speculate that the increase in oral neutrophil levels during
the experimental gingivitis phase is responsible in part for
the observed increase in whole saliva cytoprotective proteins.
Pearson correlation assessment between salivary proteins
abundance and oral neutrophils quantification demonstrated
that oral neutrophil numbers correlated moderately with
salivary β-globin and thioredoxin (R2 = 0.649 and 0.564,
respectively), and strongly with collagen alpha-1(XXVII) chain
and G-protein coupled receptor 98 (R2 = 0.883 and 0.884,
respectively), in the inflammatory and resolution phases of GI
(Figure 4).
DISCUSSION
The comparison of proteome profile at baseline and day 21 of EG
demonstrated that several salivary proteins increased by at least 2
fold during the inflammatory phase of GI. Among these proteins,
we identified 10 cytoprotective proteins. The overall increase in
these proteins, which are mostly involved in tissue protection
and inflammatory control, suggests that activation of protective
pathways, including antibacterial activity, regulation of the
inflammatory process, antioxidants, and protease inhibitors
characterizes host responses of healthy individuals to increasing
bacterial burden on the gingiva. The moderate correlation
between oral neutrophil numbers and salivary β-globin and
thioredoxin in the inflammation and resolution phases of GI
indicates that salivary antioxidantsmay not be the primary source
of protection against neutrophil-mediated oxidative damage in
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TABLE 1 | Proteins with significant change in WS levels during the inflammatory phase of EG (Day 0 vs. Day 21).
Accession Protein name Fold change p-Value
A7E2D6 NAV2 protein 1.52 0.000
A8K6R0 cDNA FLJ75726, highly similar to Homo sapiens basic leucine zipper nuclear factor 1
(JEM-1) (BLZF1), mRNA
1.92 0.004
B0I1T1 MYO1F variant protein 1.71 0.013
B0ZBF6 Mineralocorticoid receptor 1.07 0.007
B1AN48 Small proline-rich protein 3 1.03 0.000
B3KTH9 cDNA FLJ38275 fis, highly similar to GAS2-like protein 3 2.31 0.004
B3KVS4 cDNA FLJ41312 fis, clone BRAMY2042804, highly similar to Homo sapiens zinc finger
RNA binding protein (ZFR), mRNA
1.81 0.000
B3KXQ8 cDNA FLJ45892 fis, clone OCBBF3023175, highly similar to Protein neurobeachin 1.85 0.005
B4DG67 cDNA FLJ58842, highly similar to Homo sapiens zinc and ring finger 1 (ZNRF1), mRNA 1.72 0.008
B4DH81 cDNA FLJ61250, highly similar to Homo sapiens GTPase activating Rap/RanGAP
domain-like 3 (GARNL3), mRNA
1.59 0.006
B4DSR5 Kinesin-like protein KIF3B 2.23 0.013
B4DSW4 cDNA FLJ51541, moderately similar to Transcription factor Sp8 1.64 0.048
B4DT16 B-cell lymphoma/leukemia 11A 1.71 0.000
B4DVQ0 cDNA FLJ58286, highly similar to Actin, cytoplasmic 2 1.75 0.005
B4DYH2 cDNA FLJ53243 1.72 0.012
B4DYQ3 cDNA FLJ60974, highly similar to Mediator of RNA polymerase II transcription subunit
12
1.69 0.009
B7ZAX4 cDNA, FLJ79338, highly similar to Krueppel-like factor 11 1.20 0.000
B7ZMD7 Amylase, alpha 1A 0.79 0.001
C3PTT6 Pancreatic adenocarcinoma unregulated factor 2.25 0.012
C8C504 Beta-globin 1.77 0.018
C9J185 Eukaryotic translation initiation factor 2-alpha kinase 3 (Fragment) 1.64 0.006
C9JAJ5 Putative uncharacterized protein LOC349136 2.18 0.036
C9JC68 Fetuin-B (Fragment) 1.09 0.009
D3DPB9 Nitric oxide synthase trafficker, isoform CRA_a 1.09 0.031
D3DRN4 KIAA1539, isoform CRA_a 4.72 0.003
D6RGV6 Serine/threonine-protein kinase Nek11 0.72 0.005
E5KRP6 Spastin 1.88 0.036
E7EMQ1 Carbonic anhydrase 6 2.23 0.039
E7ETI5 G-protein-coupled receptor 98 3.41 0.018
E9PAV3 Nascent polypeptide-associated complex subunit alpha 1.50 0.010
E9PIJ5 Transmembrane protease serine 13 2.21 0.000
F2Z2U9 Myosin-14 1.89 0.009
F4MH44 Ubiquitously transcribed tetratricopeptide repeat protein Y-linked transcript variant 22 1.68 0.010
F5H2N0 Zinc finger protein 574 1.37 0.028
F8W696 Apolipoprotein A-I 2.32 0.027
G3CIG0 MUC19 variant 12 1.21 0.000
H0Y3D5 Fibroblast growth factor receptor 4 1.72 0.022
H0YBS7 Gamma-aminobutyric acid receptor subunit alpha-6 (Fragment) 1.72 0.002
H0YD40 Collagen alpha-1 (XXVII) chain (Fragment) 7.35 0.001
H0YL38 Zinc finger protein 280D 1.82 0.032
H6VRF8 Keratin 1 1.00 0.001
O14513 Nck-associated protein 5 1.72 0.027
O15047 Histone-lysine N-methyltransferase SETD1A 1.61 0.012
O75443 Alpha-tectorin 1.62 0.009
O75592 Probable E3 ubiquitin-protein ligase MYCBP2 1.95 0.000
O95447 Lebercilin-like protein 1.66 0.001
O95613 Pericentrin 1.55 0.026
(Continued)
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TABLE 1 | Continued
Accession Protein name Fold change p-Value
P01036 Cystatin-S 2.14 0.006
P01037 Cystatin-SN 2.33 0.046
P01833 Polymeric immunoglobulin receptor 1.10 0.007
P01834 Ig kappa chain C region 2.87 0.005
P01857 Ig gamma-1 chain C region 0.62 0.001
P01876 Ig alpha-1 chain C region 1.56 0.039
P02768 Albumin 2.33 0.022
P02774 Vitamin D-binding protein 2.78 0.001
P02788 Lactotransferrin 3.50 0.002
P02808 Statherin 1.23 0.001
P02814 Submaxillary gland androgen-regulated protein 3B 1.59 0.006
P04083 Annexin A1 4.15 0.002
P06733 Alpha-enolase 1.88 0.001
P10599 Thioredoxin 2.29 0.000
P15515 Histatin-1 1.29 0.000
P19961 Alpha-amylase 2B 0.87 0.003
P20930 Filaggrin 1.87 0.017
P22748 Carbonic anhydrase 4 0.64 0.002
P27482 Calmodulin-like protein 3 2.11 0.000
P61626 Lysozyme C 1.67 0.003
Q05BP9 OLIG2 protein 2.47 0.042
Q12912 Lymphoid-restricted membrane protein 1.21 0.001
Q12955 Ankyrin-3 0.07 0.001
Q14118 Dystroglycan 0.68 0.005
Q14484 Beta-globin 3.75 0.001
Q14515 SPARC-like protein 1 2.10 0.005
Q14C71 GLRA1 protein 1.41 0.032
Q16378 Proline-rich protein 4 0.93 0.008
Q502W4 IGKC protein 1.57 0.013
Q569J1 IGHA1 protein 1.33 0.026
Q59FG1 Calcium channel, voltage-dependent, alpha 1E subunit variant (Fragment) 1.49 0.012
Q5H9S0 Putative uncharacterized protein DKFZp781N1974 1.57 0.000
Q5JPC9 ABI gene family, member 3 (NESH) binding protein, isoform CRA_d 1.82 0.009
Q6N092 Putative uncharacterized protein DKFZp686K18196 (Fragment) 1.27 0.008
Q6PL43 Uncharacterized protein 1.96 0.014
Q6W4X9 Mucin-6 2.13 0.045
Q86UD4 Zinc finger protein 329 1.60 0.002
Q8TDL5 Long palate, lung and nasal epithelium carcinoma-associated protein 1 0.38 0.001
Q8WXI7 Mucin-16 1.99 0.000
Q96AY4 Tetratricopeptide repeat protein 28 2.20 0.020
Q96FS4 Signal-induced proliferation-associated protein 1 1.40 0.030
Q9BZG5 Androgen receptor 2.21 0.002
periodontal tissue inflammation. The inflammatory response
observed during gingivitis is mediated by neutrophils migrating
from the blood stream to the gingival tissues and in to the
oral cavity through the GCF. We speculate that the increase
in oral neutrophil levels during the experimental gingivitis
phase is responsible in part for the observed increase in
whole saliva cytoprotective proteins. The association between
oral neutrophil levels and levels of proteins of interest was
tested through correlation analysis during the experimental
gingivitis phase (days 0–21), and the healing period which
followed (days 28–35). In general, we found moderate to strong
correlations between oral neutrophil numbers and levels of
several salivary cytoprotective proteins in inflammation and
resolution of gingivitis.
Lactotransferrin (also known as lactoferrin) is an iron-binding
protein (Brock, 2002; Ammons and Copié, 2013), found in
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TABLE 2 | Proteins with significant increase of >2 fold during the inflammatory phase of EG.
Accession Protein name Fold change p-Value
B3KTH9 cDNA FLJ38275 fis, highly similar to GAS2-like protein 3 2.31 0.004
B4DSR5 Kinesin-like protein KIF3B 2.23 0.013
C3PTT6 Pancreatic adenocarcinoma unregulated factor 2.25 0.012
C9JAJ5 Putative uncharacterized protein LOC349136 2.18 0.036
D3DRN4 KIAA1539, isoform CRA_a 4.72 0.003
E7EMQ1 Carbonic anhydrase 6 2.23 0.039
E7ETI5 G-protein-coupled receptor 98 3.41 0.018
E9PIJ5 Transmembrane protease serine 13 2.21 0.000
F8W696 Apolipoprotein A-I 2.32 0.027
H0YD40 Collagen alpha-1 (XXVII) chain (Fragment) 7.35 0.001
P01036 Cystatin-S 2.14 0.006
P01037 Cystatin-SN 2.33 0.046
P01834 Ig kappa chain C region 2.87 0.005
P02768 Albumin 2.33 0.022
P02774 Vitamin D-binding protein 2.78 0.001
P02788 Lactotransferrin 3.50 0.002
P04083 Annexin A1 4.15 0.002
P10599 Thioredoxin 2.29 0.000
P27482 Calmodulin-like protein 3 2.11 0.000
Q05BP9 OLIG2 protein 2.47 0.042
Q14484 Beta-globin 3.75 0.001
Q14515 SPARC-like protein 1 2.10 0.005
Q6W4X9 Mucin-6 2.13 0.045
Q96AY4 Tetratricopeptide repeat protein 28 2.20 0.020
Q9BZG5 Androgen receptor 2.21 0.002
Highlighted proteins are proteins considered cytoprotective proteins.
serum and secreted fluids, and also present in specific neutrophil
granules (Masson et al., 1969). Its antibacterial properties
result from bacteriostatic activity, directly related to its iron-
chelating capacity; and bactericidal activity, as a result of a
direct interaction between the protein and bacteria where the
N-terminal region of LTF, known as lactoferricin, can disrupt
or possibly even penetrate bacterial cell membranes (Brock,
2002). Anti-biofilm activity of LTF was also demonstrated, as it
inhibits biofilm formation and reduces the established biofilm
of oral bacteria at physiological concentrations (Wakabayashi
et al., 2010; Ammons and Copié, 2013). It has been speculated
that LTF inhibits biofilm formation and disrupts existing
biofilm by preventing bacterial adhesion or stimulating bacterial
motility. Similar to our current findings, significant increase
in LTF abundance was previously demonstrated in GCF
samples during EG (15). The reported antibacterial and anti-
biofilm properties of LTF can explain its increased abundance
during EG, as an innate protective response to bacterial
accumulation. Due to these protective properties, LTF was
suggested as a potential treatment for CP (Wakabayashi et al.,
2010).
In addition to biofilm control-associated factors, several
anti-inflammatory proteins were changed during the course of
inflammation-resolution in our EG study. Two inflammation
regulating proteins were increased in the inflammatory phase
of EG: Annexin A1 and Vitamin D binding protein. Annexins
are a family of calcium and phospholipid binding proteins
(Gerke and Moss, 2002), which dampen the inflammatory
response via inhibition of neutrophil activation (Chatterjee
et al., 2005). Annexin A1 levels in GCF were previously
demonstrated to be stable during 21 days EG, opposing our
current findings (Grant et al., 2010). One possible explanation
is that we used WS samples and not GCF samples. Therefore,
it is possible that salivary sources contribute to annexin
A1 production and its involvement in regulating gingival
inflammation.
Vitamin D binding protein (DBP) is a multifunctional protein
found in plasma. Its ability to bind to vitamin D (calcitriol)
and its metabolites and to transfer them to target cells has a
major role in the involvement of vitamin D in inflammatory
regulation. Vitamin D was shown to be involved in both
the innate and adaptive immune systems, with vitamin D
insufficiency being linked to many inflammatory disorders,
including periodontal diseases. It has been suggested that vitamin
D may act similarly to cytokines, and regulate the inflammatory
process by several mechanisms: stimulating phagocytosis and
antibody-presenting actions to enhance the initial immune
response. As the inflammatory process progresses, vitamin
D plays a role in inhibition of T-cell proliferation and
thus inflammatory resolution (Stein et al., 2014). DBP itself
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FIGURE 3 | Cytoprotective proteins significantly increased during EG (day 21 vs. day 0). (A) WS samples were analyzed by LC-ESI-MS/MS and relative
proteome analysis performed based on peptide sequences obtained from the database search using SEQUEST algorithm after peak integration from acquired frames
and SIEVE-assisted recognition of proteins form peptide sequences. (B) Time course of salivary protein levels for select proteins that increased by >2 fold on day 21
vs. baseline. With exception of aryl hydrocarbon receptor repressor, cDNA FLJ3590 fis and lactotransferrin all proteins with >2 fold increase in the inflammatory phase
were reduced by day 35, 2 weeks after oral hygiene was resumed.
was demonstrated to have significant neutrophil chemotactic
activity in vivo where DBP knock-out mice demonstrated
significant decreases in neutrophil recruitment to the site of
infection when compared to the wild type group. Exogenous
addition of DBP was shown to restore neutrophil response
(Trujillo et al., 2013). Our observation of increased DBP levels
during EG may suggest an increased abundance of vitamin
D during this phase. High vitamin D levels were suggested
to reduce inflammation during gingivitis (Dietrich et al.,
2005).
Increases in oxidative stress, where reactive oxygen species
(ROS) levels exceed antioxidant levels, have been shown
to directly contribute to periodontal inflammation and
connective tissue breakdown during periodontal disease.
The antioxidant defense systems have an important role in
balancing physiological oxidative stress (Chapple and Matthews,
2007). Total antioxidant capacity (TAC) levels were found to
be significantly lower in periodontitis patients when compared
to healthy controls (Chapple et al., 2007). Our current findings
demonstrate an increase in antioxidant proteins–β-globin and
Thioredoxin during the development of EG, suggesting an
additional protective mechanism during this reversible phase of
periodontal disease.
The globin superfamilies are hemeproteins which can
be found in all known life forms. Its common role in
O2 transport in vertebrate erythrocytes is recognized as
a relatively recent adaptation from its more primative
functions in non-erythroid cells, including iron metabolism
regulation, intracellular oxygen transport, oxygen sensing, NO
scavenging, and hydrogen peroxide scavenging (Vinogradov
and Moens, 2008). Several human studies demonstrated that
hemoglobin overexpression reduces oxidative stress, suggesting
its cytoprotective role as an antioxidant (Liu et al., 2011; Li
et al., 2013). Increased β-globin levels were demonstrated
in mice macrophages treated with lipopolysaccharide and
interferon-γ (Liu et al., 1999). In-line with our current findings,
salivary proteome analysis of samples collected from gingivitis
patients with gingivitis revealed increase in both α- and β-
globin compared to healthy controls (Gonçalves Lda et al.,
2011).
Thioredoxin (Trx) is an intra-cellular protein that together
with thioredoxin reductase and NADPH, comprises the
thioredoxin system. This system has been shown to play a
key role in many intra-cellular pathways including H2O2 as a
means to reduce oxidative stress (Holmgren and Lu, 2010). The
cytoprotective effects of Trx were demonstrated in transgenic
mice overexpressing human Trx1 that are resistant to oxidative
stress conditions, and are more resistant to inflammation
(Yoshida et al., 2005). In humans, increased extracellular Trx
levels were reported for various systemic conditions, including
rheumatoid arthritis (RA; Maurice et al., 1999). Our current
results demonstrate an increase in Trx during EG, supporting its
protective role during this reversible inflammatory phase.
Several proteolytic enzymes have been demonstrated to
play a key role in periodontal tissue destruction. The main
sources for these enzymes are the neutrophils that populate
the periodontal pocket and produce proteolytic enzymes as
part of the non-oxidative killing function (Meyer-Hoffert and
Wiedow, 2011). We identified a significant increase in the
protease inhibitor proteins Cystatin SN and Cystatin S during
EG. Cystatins SN and S were first identified in saliva, and have
been identified in other secreted fluids. Their production in
secretory glands suggests their role as cytoprotective inhibitors
of exogenous cysteine peptidases (Abrahamson et al., 2003).
Cystatin S levels in GCF have been demonstrated to be stable
during the 21 days EG model, which once again is in contrast
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FIGURE 4 | Pearson correlation assessment between salivary proteins abundance and oral neutrophils quantification demonstrated that oral
neutrophil numbers correlated moderately with salivary β-globin (A) and thioredoxin (B) and strongly with (C) collagen alpha-1(XXVII) chain and (D)
G-protein coupled receptor 98 in the inflammatory and resolution phases of GI.
to our current findings (Grant et al., 2010). In a different
study, GCF proteome analysis reported decrease in cystatin
S abundance in GCF samples obtained from GI patients
(Huynh et al., 2014). Salivary glands contribute to cystatin S
production, which can explain the differences in our analysis
of WS samples, as opposed to GCF samples. In support of
our findings, cystatin activity was demonstrated to increase
in WS samples obtained from GI patients (Henskens et al.,
1993), as well as in inflamed gingival tissues (Babnik et al.,
1988).
The increase in cytoprotective proteins during the
development of EG, suggests that production of proteins
that can dampen the effector proteins involved in the
inflammatory process is important during inflammatory
diseases including GI (Figures 3, 4). Similar findings were
reported in a human tears study, which demonstrated increase
in cystatin S and lactotransferrin levels in tears collected
from patients with autoimmune conditions (Katunuma
et al., 2003). Interestingly, reduced levels of several of these
cytoprotective proteins were previously reported in patients
diagnosed with CP. Reduced cystatins (S, SN, SA) levels
were previously reported in WS samples obtained from
CP patients when compared to healthy controls (Henskens
et al., 1996; Ito et al., 2008; Gonçalves Lda et al., 2010).
Reports of LTF levels during CP were inconsistent: WS
proteome analysis demonstrated a 2-fold increase in LTF levels
when compared to healthy controls (Salazar et al., 2013).
Contrary to this report, low levels of LTF were demonstrated
in WS samples obtained from patients diagnosed with
Aggregatibacter actinomycetemcomitans-associated periodontitis
(Groenink et al., 1999), and in WS samples obtained from
patients diagnosed with generalized aggressive periodontitis
(GAgP) when compared to healthy controls (Wu et al., 2009).
The same study also showed increased vitamin D binding protein
levels in GAgP patients when compared to healthy controls (Wu
et al., 2009).
Several theories may explain the reduced levels of protective
proteins during CP: as the inflammatory process progresses,
increased levels of endogenous and exogenous ROS and proteases
may lead to damage of the cytoprotective proteins. A second
theory suggests that once bacterial and inflammatory overload
reach a specific threshold, the cytoprotective mechanisms are
reduced. This threshold can vary between subjects, and may be
responsible for the observed variability in the development of CP
among subjects. The findings of the present study demonstrate
that in the initial inflammatory phase of GI levels of salivary
cytoprotective proteins are increased and that they decrease as
inflammation resolves.
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CONCLUSIONS
We were able to demonstrate in the current pilot study a
significant increase in several cytoprotective proteins during the
inflammatory phase of GI. Further, we found that levels of these
proteins decreased in the healing phase of GI indicating a dose-
response relationship with gingival inflammation-resolution.
The increase in cytoprotective proteins in onset of GI may
prevent periodontal tissue destruction and clinical attachment
loss in patients at risk of developing CP due to other host
and environmental factors. Future studies to investigate whether
these proteins can serve as biomarkers for GI progression to CP
are necessary.
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